Psychology & Psychiatry

Extended-release naltrexone promising for opioid dependence

(HealthDay)—Extended-release naltrexone is noninferior to buprenorphine-naloxone for maintaining short-term abstinence from heroin and other illicit substances, according to a study published online Oct. 18 in JAMA Psychiatry.

page 9 from 24